January 26, 2010
FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).
January 04, 2010
The FDA and the Texas Department of State Health Services have notified healthcare professionals and consumers, especially pregnant or nursing women, to avoid consuming a traditional morning sickness remedy called "Nzu," because of high levels of lead and arsenic found during laboratory analysis.
December 08, 2009
Alaven's PrimaBella, a non-invasive prescription therapeutic device approved by the FDA for the treatment of nausea and vomiting due to pregnancy (NVP), has been made available.
September 16, 2009
The FDA has notified healthcare professionals that a Boxed Warning is being added to the prescribing information for promethazine hydrochloride products, describing the risks of severe tissue injury, including gangrene, requiring amputation following intravenous administration of promethazine.
July 20, 2009
A.P. Pharma announced that the FDA has accepted for review the New Drug Application (NDA) submitted for APF530 for the treatment of chemotherapy-induced nausea and vomiting (CINV).